Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56

Fine, 2007, Neuroendocrine lesions of the genitourinary tract, Adv. Anat. Pathol., 14, 286, 10.1097/PAP.0b013e3180ca8a89 Mazzucchelli, 2009, Neuroendocrine tumours of the urinary system and male genital organs: clinical significance, BJU Int., 103, 1464, 10.1111/j.1464-410X.2009.08451.x Volante, 2014, Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues, Hum. Pathol., 45, 665, 10.1016/j.humpath.2013.03.016 Moch, 2016 Gupta, 2015, High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma, Pathology, 47, 533, 10.1097/PAT.0000000000000301 Wang, 2018, Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases, Hum. Pathol., 79, 57, 10.1016/j.humpath.2018.05.005 Park, 2019, Non-urothelial carcinomas of the bladder, Histopathology, 74, 97, 10.1111/his.13719 Yao, 2006, Small cell carcinoma of the prostate: an immunohistochemical study, Am. J. Surg. Pathol., 30, 705, 10.1097/00000478-200606000-00005 Wang, 2008, Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases, Am. J. Surg. Pathol., 32, 65, 10.1097/PAS.0b013e318058a96b Lane, 2007, Renal neuroendocrine tumours: a clinicopathological study, BJU Int., 100, 1030 La Rosa, 2009, Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature, Endocr. Pathol., 20, 24, 10.1007/s12022-008-9054-y Lane, 2009, Renal neuroendocrine tumors, Indian J. Urol., 25, 155, 10.4103/0970-1591.52905 Teegavarapu, 2014, Neuroendocrine tumors of the kidney: a single institution experience, Clin. Genitourin. Cancer, 12, 422, 10.1016/j.clgc.2014.06.008 Kuroda, 2014, Review of small cell carcinoma of the kidney with focus on clinical and pathobiological aspects, Pol. J. Pathol., 65, 15, 10.5114/pjp.2014.42664 Evans, 2006, Large cell neuroendocrine carcinoma of prostate: a clinicopathologic summary of 7 cases of a rare manifestation of advanced prostate cancer, Am. J. Surg. Pathol., 30, 684, 10.1097/00000478-200606000-00003 Tu, 2019, Large cell neuroendocrine carcinoma of the prostate: a systematic review and pooled analysis, Urol. Int., 1 Lan, 2009, Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation, FASEB J., 23, 2024, 10.1096/fj.08-125971 Fujino, 2015, Insulinoma-associated protein 1 is a crucial regulator of neuroendocrine differentiation in lung Cancer, Am. J. Pathol., 185, 3164, 10.1016/j.ajpath.2015.08.018 Rosenbaum, 2015, INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms, Am. J. Clin. Pathol., 144, 579, 10.1309/AJCPGZWXXBSNL4VD Rooper, 2017, INSM1 demonstrates superior performance to the individual and combined use of Synaptophysin, Chromogranin and CD56 for diagnosing neuroendocrine tumors of the thoracic cavity, Am. J. Surg. Pathol., 41, 1561, 10.1097/PAS.0000000000000916 Kriegsmann, 2018, Insulinoma-associated protein 1 (INSM1) in thoracic tumors is less sensitive but more specific compared with synaptophysin, chromogranin a, and CD56, Appl. Immunohistochem. Mol. Morphol. Mukhopadhyay, 2019, Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections, Mod. Pathol., 32, 100, 10.1038/s41379-018-0122-7 Gonzalez, 2019, INSM1 expression in primary and metastatic neuroendocrine neoplasms of the gastrointestinal and pancreatobiliary tracts, Histopathology, 10.1111/his.13899 Kuji, 2017, A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: analysis of 37 cases, Gynecol. Oncol., 144, 384, 10.1016/j.ygyno.2016.11.020 Lilo, 2018, INSM1 is more sensitive and interpretable than conventional immunohistochemical stains used to diagnose merkel cell carcinoma, Am. J. Surg. Pathol., 42, 1541, 10.1097/PAS.0000000000001136 Leblebici, 2019, A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: evaluation of 24 cases, Ann. Diagn. Pathol., 40, 53, 10.1016/j.anndiagpath.2019.04.002 Rooper, 2018, INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors, Am. J. Surg. Pathol., 42, 665, 10.1097/PAS.0000000000001037 Xin, 2018, Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate, Hum. Pathol., 79, 151, 10.1016/j.humpath.2018.05.014 Rodriguez, 2019, Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience, Hum. Pathol., 85, 128, 10.1016/j.humpath.2018.10.035 Doxtader, 2018, Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens, Cancer Cytopathol., 126, 243, 10.1002/cncy.21972 Viswanathan, 2019, Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens, J. Am. Soc. Cytopathol. Takase, 2019, Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: an analysis of 14 patients, Cytopathology, 30, 194, 10.1111/cyt.12640 Svajdler, 2019, Hum. Pathol., 85, 58, 10.1016/j.humpath.2018.10.016 Nakra, 2019, Insulinoma-associated protein 1 is a robust nuclear immunostain for the diagnosis of small cell lung carcinoma in cytology smears, Cancer Cytopathol., 127, 539, 10.1002/cncy.22164 Abe, 2019, Insulinoma-associated protein 1 is a novel diagnostic marker of small cell lung cancer in bronchial brushing and cell block cytology from pleural effusions: validity and reliability with cutoff value, Cancer Cytopathol., 127, 598, 10.1002/cncy.22177 Tanigawa, 2018, Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor, Med. Mol. Morphol., 51, 32, 10.1007/s00795-017-0167-6 Rodriguez, 2018, Insulinoma-associated protein 1 immunostain: a diagnostic tool for pulmonary small cell carcinoma in cytology, Acta Cytol., 62, 333, 10.1159/000490091 Epstein, 2014, Proposed morphologic classification of prostate cancer with neuroendocrine differentiation, Am. J. Surg. Pathol., 38, 756, 10.1097/PAS.0000000000000208 Fine, 2018, Neuroendocrine tumors of the prostate, Mod. Pathol., 31, S122, 10.1038/modpathol.2017.164 Kumaki, 2007, Immunohistochemical analysis of neuroendocrine (NE) differentiation in testicular germ cell tumors (GCTs): use of confocal laser scanning microscopy (CLSM) to demonstrate direct NE differentiation from GCTs, Acta Histochem. Cytochem., 40, 143, 10.1267/ahc.07025 Oda, 1993, Clear cell sarcoma of kidney. Two cases in adults, Cancer, 71, 2286, 10.1002/1097-0142(19930401)71:7<2286::AID-CNCR2820710719>3.0.CO;2-3 Yoshida, 2018, CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue, Brain Pathol., 28, 710, 10.1111/bpa.12585 Argani, 2000, Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center, Am. J. Surg. Pathol., 24, 4, 10.1097/00000478-200001000-00002 Sehic, 2014, Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor, Am. J. Clin. Pathol., 141, 828, 10.1309/AJCPQ8Q0YTHSYZTX